Table 3 Logistic multivariate regression analysis of the association between IL-10 promoter polymorphisms and risk of PEX/PEXG/POAG disorders
Disorder/Haplotype | β | S.E. | Wald | P | OR (95% CI) |
|---|---|---|---|---|---|
PEX | |||||
 GCC |  |  |  |  | Ref. group |
 ACC | 1.75 | .58 | 9.19 | .002 | 5.76 (1.86–17.84) |
 GTA | 1.973 | .79 | 6.27 | .012 | 7.19 (1.53–33.70) |
 ATA | 21.57 | 1.6E+ 4 | .01 | .999 | NA |
 GCA | −20.84 | 2.8E+ 4 | .01 | .999 | NA |
PEXG | |||||
 GCC |  |  |  |  | Ref. group |
 ACC | 2.021 | .56 | 12.94 | .001 | 7.55 (2.51–22.69) |
 GTA | 1.703 | .80 | 4.49 | .034 | 5.49 (1.14–26.49) |
 ATA | 21.52 | 2.8E+ 4 | .01 | .999 | NA |
 GCA | −20.89 | 2.8E+ 4 | .01 | .999 | NA |
POAG | |||||
 GCC |  |  |  |  | Ref. group |
 ACC | 2.09 | .56 | 13.85 | .001 | 8.11 (2.69–24.43) |
 GTA | 1.99 | .79 | 6.43 | .011 | 7.37 (1.57–34.56) |
 ATA | 21.59 | 2.8E+ 4 | .01 | .999 | NA |
 GCA | −20.81 | 2.8E+ 4 | .01 | .999 | NA |